StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) income statement

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.99−0.41 (-2.85%)

Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –

HUTCHMED (China) Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
38.7%
Operating margin
-7.1%
Net margin
83.3%
Return on equity, FY2025
45.7%

Financial strength

Current ratio
5.64
Debt to equity
0.09
Debt to assets
6.7%
Cash to current liabilities
38.7%

Valuation

P/E ratio
5.4
Price to sales
4.45
Price to book
1.94
Dividend yield
–

See a number that looks wrong?